HCPCS 2013 Code Changes
Part B Insider
| New | ||
| Code | Description | |
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | |
| G0454 | Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist | |
| G8939 | Pain assessment documented, follow-up plan not documented, patient not eligible/appropriate | |
| G8941 | Elder maltreatment screen documented, patient not eligible for follow-up | |
| G8942 | Documented functional outcomes assessment and care plan within the previous 30 days | |
| G8949 | Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e. G. , patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes) | |
| G8954 | Complete and appropriate patient data were reported to a qualified clinical database registry | |
| Q5101 | Injection, filgrastim (G-CSF), biosimilar, 1 microgram | |
| Revised | |
| Code | Descriptor |
| No Revised HCPCS code for 2013 | |
| Deleted | |
| Code | Descriptor |
| G8447 | Patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb) |
| G8448 | Patient encounter was documented using a pqri qualified ehr or other acceptable systems |
| G9141 | Influenza a (h1n1) immunization administration (includes the physician counseling the patient/family) |
| G9142 | Influenza a (h1n1) vaccine, any route of administration |
| C9452 | Injection, ceftolozane 50 mg and tazobactam 25 mg |
| C9454 | Injection, pasireotide long acting, 1 mg |
| C9455 | Injection, siltuximab, 10 mg |
| J0886 | Injection, epoetin alfa, 1000 units (for ESRD on dialysis) |
| J1446 | Injection, TBO-filgrastim, ?5 micrograms |
| J7506 | Prednisone, oral, per 5 mg |
| Q9975 | Injection, factor VIII FC fusion (recombinant), per iu |
| Q9979 | Injection, alemtuzumab, 1 mg |
| S5011 | 5% dextrose in lactated ringer's, 1000 ml |
| S8262 | Mandibular orc repositioning device, each |